Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A study in two groups of healthy male adult participants to assess pharmacokinetics and oral bioavailability of SAR441566
2023-508030-33-00Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of balinatunfib (2 arms), sponsored by Sanofi. Primary endpoints: Pharmacokinetic parameters of SAR441566 and Oral bioavailability of SAR441566. Started Feb 2024; status: completed.
02
Drugs
balinatunfib
Beyond the preview
Go deeper on 2023-508030-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508030-33-00.